Free shipping on all orders over $ 500

Lixumistat

Cat. No. M9911

All AbMole products are for research use only, cannot be used for human consumption.

Lixumistat Structure
Synonym:

IM156; HL156A

Size Price Availability Quantity
5mg USD 160  USD160 In stock
10mg USD 245  USD245 In stock
25mg USD 460  USD460 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat (IM156) is a metformin derivative, which increases AMPK phosphorylation. Lixumistat (IM156) treatment of RPMCs inhibits HG-induced myofibroblast transdifferentiation and markers of epithelial-mesenchymal transition (EMT). Moreover, Lixumistat (IM156) ameliorates HG-induced transforming growth factor-β1, Smad3, Snail, and fibronectin expression in the RPMCs via AMPK upregulation. Lixumistat (IM156) treatment impaires the function of virus-specific memory CD8+ T cells, indicating that excessive AMPK activation weakens memory T cell differentiation, thereby suppressing recall immune responses. Lixumistat also suppresses B-cell activation to alleviate systemic lupus erythematosus.

Chemical Information
Molecular Weight 315.29
Formula C13H16F3N5O
CAS Number 1422365-93-2
Solubility (25°C) DMSO 32 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Said Izreig, et al. Cell Rep Med. Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment

[2] Jimin Son, et al. Immune Netw. Metabolic Reprogramming by the Excessive AMPK Activation Exacerbates Antigen-Specific Memory CD8 + T Cell Differentiation after Acute Lymphocytic Choriomeningitis Virus Infection

[3] Kyung Don Ju, et al. Am J Physiol Renal Physiol. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis

Related Mitochondrial Related Products
NL-1

NL-1 is a mitoNEET inhibitor with antileukemic effect. NL-1 inhibits REH and REH/Ara-C cells growth with IC50 values of 47.35 μM and 56.26 μM, respectively.

Malonyl CoA lithium

Malonyl CoA lithium is an inhibitor of carnitine palmitoyl transferase 1 (CPT1). Malonyl Coenzyme A lithium (Malonyl CoA lithium) is an important precursor for the production of a variety of chemicals that modulate insulin-stimulated glucose transport in myotubes. Malonyl Coenzyme A is a coenzyme A derivative that is utilized in fatty acid and polyketide synthesis and in the transport of α-ketoglutarate across the mitochondrial membrane.

MFI8 

MFI8 is a small molecule inhibitor of mitochondrial.

GW604714X 

GW604714X is a potent inhibitor of mitochondrial respiration supported by pyruvate but not other substrates.

Antimalarial agent 14 

Antimalarial agent 14 is a potent inhibitor of mitochondrial electron transport.

  Catalog
Abmole Inhibitor Catalog




Keywords: Lixumistat, IM156; HL156A supplier, Mitochondrial Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.